SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Louis Riley who wrote (101)9/27/1997 12:29:00 AM
From: Bradpalm1   of 23519
 
All these witless criticisms about Viagra and Vasomax are quite amusing. Their efficacy and safety profiles are really quite impressive and they'll quickly capture the untapped psychogenic/recreational markets without any difficulty. To discount them is foolish.

These oral medications also DON'T depend on variable drug transfer between the corpus spongiosum and the corpora cavernosa to start things going. We're still dealing with cyclic nucleotides, nitric oxide and VIP as the final common mediators of smooth muscle relaxation whether we're talking about alprostadil or sildenafil. The difference is how the medication gets there and how much the pump gets primed.

Finally, penile erection is a NEUROvascular event. Letting the brain do some of the work can only make it more of a natural physiological process as God intented. Shoving a pellet up your urethra holds no joy for many sufferers of ED.

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News